Literature DB >> 21893277

Alcoholic hepatitis: prognostic models and treatment.

Ashwani K Singal1, Vijay H Shah.   

Abstract

Alcoholic hepatitis is a distinct subset of alcoholic liver disease. Inflammation and oxidative stress are the two main pathogenetic mechanisms involved in its pathogenesis. Patients with mild disease usually improve with conservative management. However, about 30-50% of those with severe disease succumb to their illness within about 1 month. Therefore, assessment of disease severity is important and practical issue. Currently, hepatologists do not have an ideal scoring system available. With survival benefit of only about 50% with corticosteroids and pentoxifylline, there is need to develop newer and better treatment options to manage these patients. This article also deals with controversies surrounding the role and use of liver transplantation in patients with alcoholic hepatitis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21893277     DOI: 10.1016/j.gtc.2011.06.008

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  14 in total

1.  Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice.

Authors:  Hyo-Jung Kwon; Young-Suk Won; Ogyi Park; Dechun Feng; Bin Gao
Journal:  Hepatology       Date:  2014-01-21       Impact factor: 17.425

2.  Refining criteria for liver biopsy in severe alcoholic hepatitis: Moving the field forward.

Authors:  Geralyn Palmer; Ashwani K Singal
Journal:  United European Gastroenterol J       Date:  2020-09-01       Impact factor: 4.623

3.  New drug targets for alcoholic liver disease.

Authors:  Mingjiang Xu; Binxia Chang; Stephanie Mathews; Bin Gao
Journal:  Hepatol Int       Date:  2014-03-08       Impact factor: 6.047

4.  Liver transplantation for alcoholic liver disease among Canadian transplant centres: a national study.

Authors:  Natasha Chandok; Mohammed Aljawad; Angela White; Roberto Hernandez-Alejandro; Paul Marotta; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2013-09-13       Impact factor: 3.522

5.  Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?

Authors:  Mercedes Amieva-Balmori; Scherezada María Isabel Mejia-Loza; Roberto Ramos-González; Felipe Zamarripa-Dorsey; Eli García-Ruiz; Nuria Pérez Y López; Eumir I Juárez-Valdés; Adriana López-Luria; José María Remes-Troche
Journal:  World J Hepatol       Date:  2015-08-18

Review 6.  Liver transplantation in alcoholic liver disease current status and controversies.

Authors:  Ashwani K Singal; Khushdeep S Chaha; Khalid Rasheed; Bhupinderjit S Anand
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

Review 7.  Alcoholic hepatitis: current challenges and future directions.

Authors:  Ashwani K Singal; Patrick S Kamath; Gregory J Gores; Vijay H Shah
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-28       Impact factor: 11.382

8.  The Worsening Profile of Alcoholic Hepatitis in the United States.

Authors:  Tuyet A Nguyen; Jonathan P DeShazo; Leroy R Thacker; Puneet Puri; Arun J Sanyal
Journal:  Alcohol Clin Exp Res       Date:  2016-05-05       Impact factor: 3.455

Review 9.  Cellular Abnormalities and Emerging Biomarkers in Alcohol-Associated Liver Disease.

Authors:  Ashwani K Singal; Shannon M Bailey
Journal:  Gene Expr       Date:  2018-07-25

Review 10.  Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review.

Authors:  Ashwani K Singal; Sudha Kodali; Lee A Vucovich; Victor Darley-Usmar; Thomas D Schiano
Journal:  Alcohol Clin Exp Res       Date:  2016-06-02       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.